methotrexate has been researched along with Postpartum Amenorrhea in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (40.00) | 18.7374 |
1990's | 9 (20.00) | 18.2507 |
2000's | 12 (26.67) | 29.6817 |
2010's | 6 (13.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arthur, R; Kroft, J; Sabra, S; Wolfman, W | 1 |
Chung, HC; Hong, S; Jeung, HC; Jung, M; Kim, HS; Moon, YW; Oh, KJ; Rha, SY; Roh, JK; Shin, HJ; Yang, WI | 1 |
Rodríguez-Lescure, A | 1 |
Alavi, N; Bahrami, A; Djavid, GE; Heidari, K; Mehrdad, N; Najafi, M; Najafi, S; Olfatbakhsh, A; Rajaii, E | 1 |
Rhemrev, JP; Smeets, MJ; van Esch, EM | 1 |
Han, HS; Jung, S; Kang, HS; Kim, SW; Lee, H; Lee, KS; Lee, S; Park, IH; Ro, J | 1 |
Blamey, R; Cuzick, J; de Haes, JC; de Matteis, A; Eiermann, W; Fogelman, I; Geberth, M; Jonat, W; Kaufmann, M; Lisboa, B; Namer, M; Palmer, M; Sauerbrei, W; Schumacher, M; Stewart, A; Szakolczai, I | 1 |
Blake, GM; Blamey, R; Fogelman, I; Palmer, M; Sauerbrei, W; Schumacher, M; Serin, D; Stewart, A; Wilpshaar, W | 1 |
Bonetti, M; Castiglione-Gertsch, M; Coates, AS; Colleoni, M; Gelber, RD; Goldhirsch, A; Nasi, ML; O'Neill, A; Price, KN | 1 |
Allen, KA; Balducci, L; Bercu, BB; Cantor, A; Jacobsen, PB; Kumar, N; Minton, S; Riccardi, D | 1 |
Bonadonna, G; Daidone, MG; Gianni, L; Moliterni, A; Pilotti, S; Valagussa, P; Zambetti, M | 1 |
Qian, JH; Xie, X; Ye, DF | 1 |
Bramwell, V; Day, AG; Levine, M; Ottaway, JA; Parulekar, WR; Pritchard, KI; Shepherd, LE; Trudeau, ME | 1 |
Aebi, S; Bernhard, J; Castiglione-Gertsch, M; Coates, AS; Collins, J; Forbes, JF; Gelber, RD; Goldhirsch, A; Hürny, C; Murray, E; Price, KN; Thürlimann, B; Zahrieh, D | 1 |
Camano, L; Elito Junior, J | 1 |
Castiglione-Gertsch, M; Gelber, RD; Gelber, S; Goldhirsch, A; Partridge, A; Winer, E | 1 |
Bulbrook, RD; Bush, H; Crowther, D; Fentiman, IS; George, WD; Hayward, JL; Howat, JM; Howell, A; Rubens, RD; Sellwood, RA | 1 |
Glatstein, E; Rosenberg, SA; Shamberger, RC; Sherins, RJ; Ziegler, JL | 1 |
Bajetta, E; Bonadonna, G; Marchini, S; Rossi, A; Tancini, G; Valagussa, P; Veronesi, U | 1 |
Bajetta, E; Banfi, A; Bonadonna, G; Brambilla, C; Marchini, S; Rossi, A; Tancini, G; Tesoro Tess, JD; Valagussa, P; Veronesi, U | 1 |
Bianco, AR; Costantini, M; Del Mastro, L | 1 |
Del Mastro, L; Rosso, R; Sertoli, MR; Venturini, M | 1 |
Castiglione, M; Cavalli, F; Coates, A; Collins, J; Crivellari, D; Fey, M; Gelber, RD; Goldhirsch, A; Lindtner, J; O'Neill, A; Pagani, O; Price, K; Rudenstam, CM; Senn, HJ; Simoncini, E; Thürlimann, B | 1 |
Blau, R; Gazder, P; Lower, EE; Tummala, R | 1 |
Hattori, T; Matsuda, M; Seki, S; Tabata, K | 1 |
Ahokoski, O; Irjala, K; Kailajärvi, M; Salminen, E; Virtanen, A | 1 |
Blomqvist, C; Elomaa, I; Mäkelä, P; Saarto, T; Välimäki, M; Vehmanen, L | 1 |
Banfi, A; Bonadonna, G; Rossi, A; Valagussa, P; Veronesi, U | 1 |
Recchione, C; Rossi, A | 1 |
Geiger, W; Künzig, HJ; Schmidt-Rhode, P; Schulz, KD; Weymar, P | 1 |
Addamo, GF; Coialbu, T; Costantini, M; Giacchero, A; Guido, T; Repetto, L; Rosso, R; Toma, S | 1 |
Balar, DB; Bhatavdekar, JM; Ghosh, N; Giri, DD; Karelia, NH; Patel, DD; Shah, NG; Trivedi, SN; Vora, HH | 1 |
Beattie, CW; Das Gupta, TK; Mehta, RR | 1 |
Falliers, CJ | 1 |
Tormey, DC | 1 |
Andersen, KW; Brincker, H; Dombernowsky, P; Mouridsen, HT; Rose, C | 1 |
Howell, A; Padmanabhan, N; Rubens, RD | 1 |
Cortese, P; De Fabiani, E; Giai, M; Giardina, G; Lamberto, A | 1 |
Andersen, KW; Brincker, H; Dombernowsky, P; Jakobsen, A; Mouridsen, HT; Panduro, J; Rank, F; Rose, C | 1 |
Beex, LV; Benraad, TJ; Kloppenborg, PW; Mackenzie, MA; Raemaekers, JM; Smals, AG | 1 |
Buzdar, AU; Hortobagyi, GN; Marcus, CE; Smith, TL | 1 |
Moore, JW; Padmanabhan, N; Rubens, RD; Wang, DY | 1 |
Citarella, F; Contegiacomo, A; d'Istria, M; De Placido, S; De Sio, L; Delrio, G; Fasano, S; Iaffaioli, RV; Marinelli, A; Pagliarulo, C | 1 |
Dillon, HJ; Dnistrian, AM; Fracchia, AA; Greenberg, EJ; Hakes, TB; Schwartz, MK | 1 |
2 review(s) available for methotrexate and Postpartum Amenorrhea
Article | Year |
---|---|
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study.
Topics: Adult; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Treatment Outcome | 2005 |
Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications.
Topics: Amenorrhea; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Melphalan; Methotrexate; Premenopause; Prognosis; Thiotepa; Vinblastine | 1997 |
16 trial(s) available for methotrexate and Postpartum Amenorrhea
Article | Year |
---|---|
Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF).
Topics: Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Femur Neck; Fluorouracil; Goserelin; Humans; Lumbar Vertebrae; Methotrexate; Premenopause | 2003 |
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
Topics: Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Confidence Intervals; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Goserelin; Humans; Incidence; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause; Receptors, Estrogen; Survival Analysis; Treatment Outcome | 2003 |
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Goserelin; Hot Flashes; Humans; Methotrexate; Middle Aged; Premenopause; Quality of Life; Treatment Outcome | 2007 |
Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Proportional Hazards Models | 2007 |
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone | 1984 |
Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of Milan.
Topics: Adult; Aged; Amenorrhea; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Mastectomy; Methotrexate; Middle Aged; Random Allocation | 1980 |
Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
Topics: Aged; Amenorrhea; Axilla; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Prognosis | 1981 |
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
Topics: Adult; Age Distribution; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause | 1998 |
Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment.
Topics: Absorptiometry, Photon; Administration, Oral; Adult; Amenorrhea; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Bone Demineralization, Pathologic; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Cyclophosphamide; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Methotrexate; Middle Aged; Ovarian Diseases; Prospective Studies | 2001 |
The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.
Topics: Amenorrhea; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Thrombocytopenia | 1977 |
Hormonal study in patients developing amenorrhea during adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Amenorrhea; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Estradiol; Female; Fluorouracil; Hormones; Humans; Luteinizing Hormone; Methotrexate; Middle Aged; Ovary; Prolactin; Thyrotropin | 1979 |
Castration induced by cytotoxic chemotherapy.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Random Allocation | 1989 |
A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Menstruation; Methotrexate; Middle Aged; Ovary; Prednisone; Random Allocation | 1985 |
Mechanism of action of adjuvant chemotherapy in early breast cancer.
Topics: Adult; Age Factors; Aged; Amenorrhea; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Middle Aged; Postoperative Period; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Time Factors | 1986 |
Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Menstrual Cycle; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovariectomy; Prognosis; Prospective Studies; Random Allocation; Receptors, Estrogen; Time Factors | 1987 |
Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute.
Topics: Adult; Alopecia; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; United States | 1986 |
27 other study(ies) available for methotrexate and Postpartum Amenorrhea
Article | Year |
---|---|
Unexplained amenorrhea in a patient taking methotrexate for the treatment of rheumatoid arthritis.
Topics: Adult; Amenorrhea; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Methotrexate | 2010 |
The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up.
Topics: Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Premenopause; Survival Rate; Tamoxifen; Treatment Outcome | 2010 |
Adjuvant chemotherapy in young women with breast cancer.
Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Genes, erbB-2; Humans; Methotrexate; Primary Ovarian Insufficiency; Risk Factors; SEER Program; Taxoids | 2010 |
Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea.
Topics: Adult; Amenorrhea; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Risk Factors; Taxoids; Treatment Outcome | 2011 |
Treatment with methotrexate of a cornual pregnancy following endometrial resection.
Topics: Abortifacient Agents, Nonsteroidal; Amenorrhea; Endometrium; Female; Humans; Menorrhagia; Methotrexate; Middle Aged; Obstetric Surgical Procedures; Pregnancy; Pregnancy, Tubal | 2012 |
Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Menstrual Cycle; Methotrexate; Middle Aged; Multivariate Analysis; Premenopause; Prognosis; Proportional Hazards Models; Retrospective Studies; Taxoids; Young Adult | 2012 |
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
Topics: Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Goserelin; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Premenopause; Receptors, Estrogen | 2002 |
Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: is subclinical hypothyroidism the culprit?
Topics: Adult; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Estradiol; Fatigue; Female; Fluorouracil; Humans; Hypothyroidism; Methotrexate; Middle Aged; Prospective Studies; Sleep Stages; Thyroxine; Weight Gain | 2004 |
[Clinical analysis of 13 cases of gestational trophoblastic tumor misdiagnosed as ectopic pregnancy].
Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole, Invasive; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Pregnancy, Ectopic; Retrospective Studies; Uterine Neoplasms | 2005 |
Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Incidence; Methotrexate; Middle Aged; Premenopause; Prognosis; Retrospective Studies; Risk Factors | 2005 |
Unruptured tubal pregnancy: different treatments for early and late diagnosis.
Topics: Abortifacient Agents, Nonsteroidal; Amenorrhea; Chorionic Gonadotropin, beta Subunit, Human; Early Diagnosis; Female; Gestational Age; Humans; Injections, Intramuscular; Methotrexate; Pregnancy; Pregnancy, Ectopic; Prospective Studies; Statistics, Nonparametric; Ultrasonography | 2006 |
Effects of postoperative adjuvant chemotherapy and radiotherapy on ovarian function in women undergoing treatment for soft tissue sarcoma.
Topics: Adolescent; Adult; Amenorrhea; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Methotrexate; Ovary; Sarcoma; Soft Tissue Neoplasms | 1981 |
Adjuvant chemotherapy in breast cancer.
Topics: Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Methotrexate; Premenopause; Time Factors; Treatment Outcome | 1995 |
The risk of premature menopause induced by chemotherapy for early breast cancer.
Topics: Adult; Amenorrhea; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Menopause, Premature; Methotrexate; Primary Ovarian Insufficiency; Retrospective Studies; Risk Factors; Time Factors | 1999 |
[A case of non-Hodgkin lymphoma in the central nervous system, developing during treatment of galactorrhea amenorrhea syndrome].
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Galactorrhea; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Prednisone; Syndrome; Treatment Outcome; Vincristine; Whole-Body Irradiation | 1999 |
Alterations in laboratory test results during adjuvant breast cancer treatment.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Chemistry Tests; Cyclophosphamide; Diagnosis, Differential; Female; Fluorouracil; Follow-Up Studies; Hematologic Tests; Hormones; Humans; Lipids; Methotrexate; Middle Aged; Reference Values | 2000 |
The effect of combination chemotherapy on ovarian, hypothalamic and pituitary function in patients with breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Hypothalamus; Luteinizing Hormone; Menopause; Menstruation Disturbances; Methotrexate; Middle Aged; Ovary; Pituitary Gland | 1979 |
Chemotherapy-induced amenorrhea and other clinical and pathological parameters in the prognosis of breast cancer patients.
Topics: Adult; Amenorrhea; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Multivariate Analysis; Ovary; Prognosis; Retrospective Studies | 1992 |
Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen.
Topics: Adult; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Endocrine Glands; Estradiol; Female; Fluorouracil; Gonadotropins; Humans; Menopause; Methotrexate; Middle Aged; Ovary; Pituitary Gland; Progesterone; Prolactin; Tamoxifen; Testosterone | 1992 |
Endocrine profile in breast cancer patients receiving chemotherapy.
Topics: Adult; Age Factors; Amenorrhea; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Estradiol; Estrone; Female; Fluorouracil; Hormones; Humans; Luteinizing Hormone; Methotrexate; Middle Aged; Obesity; Prolactin | 1992 |
Cancer chemotherapy: hormonal changes and recurring asthma.
Topics: Adenocarcinoma; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Asthma; Breast Neoplasms; Cyclophosphamide; Drug Hypersensitivity; Female; Fluorouracil; Humans; Methotrexate; Recurrence | 1991 |
Endocrine effects of adjuvant chemotherapy in premenopausal women: suggestions for the future.
Topics: Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Meta-Analysis as Topic; Methotrexate; Tamoxifen | 1989 |
[Secondary effects of adjuvant therapy].
Topics: Alopecia; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cystitis; Doxorubicin; Drug Eruptions; Female; Fluorouracil; Heart; Humans; Methotrexate; Mitolactol; Mitomycins; Neoplasms | 1985 |
Adjuvant chemotherapy in premenopausal patients with primary breast cancer; relation to drug-induced amenorrhoea, age and the progesterone receptor status of the tumour.
Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Male; Menopause; Methotrexate; Middle Aged; Receptors, Progesterone | 1988 |
Ovarian function and adjuvant chemotherapy for early breast cancer.
Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Hormones; Humans; Menopause; Methotrexate; Middle Aged | 1987 |
Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Hypothalamo-Hypophyseal System; Mastectomy; Menopause; Methotrexate; Middle Aged; Ovarian Function Tests; Ovary; Pituitary Function Tests; Tamoxifen; Time Factors | 1986 |
Chemohormonal therapy and endocrine function in breast cancer patients.
Topics: Adult; Amenorrhea; Androgens; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Estrogens; Female; Fluorouracil; Hormones; Humans; Menopause; Methotrexate; Pituitary Hormones; Prednisone; Prolactin; Tamoxifen; Vincristine | 1985 |